Sant

RESET Bioscience Announces Retail Launch at SHOWFIELDS

Retrieved on: 
Wednesday, July 20, 2022
Running, Music of Asia, Art Basel, Water, Sant, Partnership, Solution, Energy, Nature, Power, Hydration, Science, Heart, Lincoln Road, Doctor of Philosophy, Balance, Function, Amazon

MIAMI, July 20, 2022 /PRNewswire/ -- RESET Bioscience, an advanced wellness company that powers premium, natural ingredients with Powered by Santé™ lipid encapsulation technologies for maximum absorption, is excited to announce its distribution partnership through SHOWFIELDS' online shopping experience and at their Miami, FL retail location.

Key Points: 
  • Located at 530 Lincoln Road, SHOWFIELDS' Miami offers a one-of-a-kind experience that exudes the ethos of the vibrant city.
  • "The heart of RESET Bioscience is loyal to creating revolutionary breakthroughs rooted in science to bring cleaner, more efficacious wellness solutions directly to our consumers through innovative products,," says Ashley Ferguson, President of RESET.
  • RESET Bioscience can be purchased online at SHOWFIELDS.com or instore in Miami, Florida beginning Monday, July 18, 2022 through January 23, 2023.
  • RESET products, featuring Powered by Sant Delivery Technology, empower you to RESET your wellness ritual with efficacious solutions to support you from morning until night.

Us Weekly Launches UsNow.com eCommerce Shop Featuring the Hottest Celebrity-inspired Products

Retrieved on: 
Monday, April 25, 2022
Elixir, News, Us Weekly, Wellness, VIP, Marketing, The National Farm and Home Hour, Sant, Fashion merchandising, DTC, Human, Sustainability, Love, Ecosystem, Digital, Solution, Multimedia, E-commerce, Skin cream, Hair, View, Nightclub, Fashion, Cosmetics, Online shopping, Public relations, Beauty, Health

NEW YORK, April 25, 2022 /PRNewswire/ -- For decades, millions of fans have trusted Us Weekly for the latest celebrity and entertainment news online and at the newsstand. Now, trend-seekers can explore, discover, and purchase the hottest celebrity-inspired products with a few simple clicks at UsNow.com.

Key Points: 
  • Now, trend-seekers can explore, discover, and purchase the hottest celebrity-inspired products with a few simple clicks at UsNow.com .
  • Trending brands by category include:
    Danish protective eyewear Christopher Cloos created in collaboration with supermodel Elsa Hosk and legendary quarterback Tom Brady.
  • Shoppers and pop-culture enthusiasts can also browse " Get TheLook ," a shoppable page featuring the latest style duds and adorn accessories worn by celebrities.
  • We deliver consumer products to over 65,000 retail locations weekly and have a 100-year track record of growing brands through logistics, sales, sourcing, marketing, and media.

Cordis Makes Strategic Investment in E2, a developer of Next-Generation Thrombectomy Devices

Retrieved on: 
Tuesday, April 5, 2022
Pelvis, Thrombosis, BD (company), Heart, Partnership, Leg, Growth, Patient, Boston Scientific, Matin, Celgene, History, CEO, Quality of life, Coronary artery disease, Technology, Stroke, Physician, Creativity, Solution, DVT, Sant, PE, Pharmaceutical industry, Cordis, E2, Exploris

MIAMI LAKES, Fla., April 5, 2022 /PRNewswire/ -- Cordis today announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the Venous Thromboembolism Market (VTM) with a strategic investment in Endovascular Engineering ("E2"), a developer of next-generation thrombectomy devices to treat patients with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). 

Key Points: 
  • "Our investment in E2 positions Cordis at the vanguard of innovation in venous interventions," said Duke Rohlen, Executive Chairman of Cordis and CEO of Cordis-X, an independent accelerator created to drive innovation and growth for Cordis.
  • "We are proud to support the team's efforts to define a new standard of care for patients suffering from thromboembolism."
  • Cordis is partnering with SantVentures and another strategic investor in the E2 transaction.
  • The investment in E2 supports Cordis' legacy as a leader in creating lifesaving cardiovascular technologies."

Canada's National Strategy for Drugs for Rare Diseases Needs a Holistic Approach

Retrieved on: 
Wednesday, December 8, 2021
Data collection, Benefit, TAK, Takeda, Patient, Takeda Pharmaceutical Company, Standards for Better Health, Case report, Quality of life, Forum, Degenerative disease, Sant, DRD, R, Science, Vaccine, Policy, General manager, Rare, Translation, Marketing, Diagnosis, Health Canada, National Strategy for Trusted Identities in Cyberspace, Investment, Federal, Pharmaceutical industry, Medical device

Takeda's longstanding commitment to Drugs for Rare Diseases (DRD) and extensive global footprint provides a unique opportunity to assess and summarize best practices on how different countries have developed their own tailored approaches to expediting and expanding access to new treatments for rare diseases.

Key Points: 
  • Takeda's longstanding commitment to Drugs for Rare Diseases (DRD) and extensive global footprint provides a unique opportunity to assess and summarize best practices on how different countries have developed their own tailored approaches to expediting and expanding access to new treatments for rare diseases.
  • Many jurisdictions have adopted a holistic approach to treating rare diseases one that embeds a set of specific protocols and processes within an overarching policy framework that incorporates multiple measures to support people with rare disease needs.1These countries recognize that drugs for rare diseases are only one essential part of a robust rare disease strategy.
  • The strategy must also address improved screening, timely diagnosis, data collection and patient and caregiver support.
  • "Canada has the unique opportunity to learn from other jurisdictions to create real and meaningful change for Canadians living with rare diseases.

Santé Medical Aesthetics Hires Chelsea R. Klinke as Vice President of Sales and Operations

Retrieved on: 
Thursday, December 20, 2018
Aesthetics, Prequels, Sant

Prior to joining Sant Medical Aesthetics, Klinke played a vital role in the growth of a $150 million per year, 200 site aesthetic services organization which led to its private equity acquisition.

Key Points: 
  • Prior to joining Sant Medical Aesthetics, Klinke played a vital role in the growth of a $150 million per year, 200 site aesthetic services organization which led to its private equity acquisition.
  • As part of expanding the Sant executive team, A. Fawad Ghafoori, CEO of Sant Medical Aesthetics recognized the hiring of Klinke as a crucial step toward growing the Sant brand regionally and nationally.
  • Sant Medical Aesthetics specializes in providing leading, non-invasive aesthetic procedures and wellness counseling that turn back the clock to restore the most attractive, healthy version of each guest.
  • For more information, contact Sant Medical Aesthetics at (817) 305-0050.

Composer Danny Elfman Reunites With Director Gus Van Sant With His Original Score For Don't Worry, He Won't Get Far On Foot

Retrieved on: 
Friday, July 13, 2018
Film, Cinema of the United States, Culture, English-language films, Don't Worry, He Won't Get Far on Foot, Gus Van Sant, Van Sant, Good Will Hunting, Milk, Danny Elfman, Anonymous Content, Sant

Elfman won two of his Oscar nominations for a pair of memorable Van Sant films Milk (2008) and Good Will Hunting (1997).

Key Points: 
  • Elfman won two of his Oscar nominations for a pair of memorable Van Sant films Milk (2008) and Good Will Hunting (1997).
  • "The amazing and brilliant score for Don't Worry, He Won't Get Far on Foot is one of my favorite Danny Elfman musical compositions," Van Sant writes, in his liner note for the original soundtrack recording.
  • "It has one foot in stark reality, while the other foot has a sense of humor."
  • Amazon Studios presents an Iconoclast/Anonymous Content production of a Gus Van Sant film Don't Worry, He Won't Get Far on Foot.